Measuring the Financial Burden of Resistance: What Should Be Compared?

Clin Infect Dis. 2019 Aug 30;69(6):1082. doi: 10.1093/cid/ciz096.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carbapenems
  • Cost of Illness
  • Health Expenditures
  • Humans
  • Infections*
  • Klebsiella pneumoniae*

Substances

  • Carbapenems